Your browser doesn't support javascript.
loading
Clinical and molecular characterization of myeloid sarcoma without medullary leukemia.
Abbas, Hussein A; Reville, Patrick K; Geppner, Alexis; Rausch, Caitlin R; Pemmaraju, Naveen; Ohanian, Maro; Sasaki, Koji; Borthakur, Gautam; Daver, Naval; DiNardo, Courtney; Bueso-Ramos, Carlos; Pierce, Sherry; Jabbour, Elias; Garcia-Manero, Guillermo; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Kadia, Tapan M.
Afiliação
  • Abbas HA; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Reville PK; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Geppner A; Division of Cancer Medicine, Medical Oncology Fellowship, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rausch CR; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pemmaraju N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ohanian M; Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sasaki K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Borthakur G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daver N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • DiNardo C; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bueso-Ramos C; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pierce S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Konopleva M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kadia TM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leuk Lymphoma ; 62(14): 3402-3410, 2021 12.
Article em En | MEDLINE | ID: mdl-34380367
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Sarcoma Mieloide Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Sarcoma Mieloide Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos